Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents
- 1 April 1995
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 25 (5) , 1069-1075
- https://doi.org/10.1016/0735-1097(94)00528-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase)The American Journal of Cardiology, 1994
- Nonionic Contrast Media Procoagulants or Clotting Innocents?Investigative Radiology, 1993
- Fibrin modification by ionic and nonionic contrast media during cardiac catheterizationThe American Journal of Cardiology, 1992
- Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complicationsThe American Journal of Cardiology, 1992
- Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectorisThe American Journal of Cardiology, 1990
- Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: Analysis of 8,517 patientsThe American Journal of Cardiology, 1990
- Coronary arteriography 1984–1987: A report of the registry of the society for cardiac angiography and interventions. I. Results and complicationsCatheterization and Cardiovascular Diagnosis, 1989
- Prolonged infusion of urokinase for recanalization of chronically occluded aortocoronary bypass graftsThe American Journal of Cardiology, 1988
- Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosisThe American Journal of Cardiology, 1986
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984